Acute Myeloid Leukemia Kmt2a-rearranged

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-09
Clinical Trial Update: Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML [Phase 3]
Phase 3 clinical trial updating a study of Ziftomenib in combination with venetoclax and azacitidine or standard 7+3 induction for newly dia…